"R&D for Development for Neglected Diseases. How Can India Contribute"
Sudip Chaudhuri, India Institute of Management
It is increasingly being realised that to take care of the market failure to generate R&D for new drugs for the neglected diseases, developing countries themselves will have to play an important role. The focus of this paper in on India. India is important for several reasons. In line with TRIPS, India has introduced a product patent regime in pharmaceuticals from 1 January, 2005. Will this lead to an increase in resources devoted to R&D by Indian companies for the development of new drugs more suited to the needs of India and other developing countries? India has demonstrated strong innovation capabilities in developing manufacturing processes. Can such capabilities be utilized for developing new drugs particularly for neglected diseases? Can India contribute to lowering the cost of new drug development and hence make drugs more accessible?